{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:32:46Z","timestamp":1783780366646,"version":"3.55.0"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Graves\u2019 disease (GD) is the leading cause of autoimmune hyperthyroidism, though pediatric cases are uncommon. Methimazole (MMI) is the first-line therapy; however, drug-induced lupus erythematosus (DILE) secondary to MMI is rare and may be overlooked. We report the case of a 16-year-old girl with newly diagnosed GD who developed inflammatory polyarthritis, a diffuse pruritic maculopapular rash, and alopecia within 1\u2005week of starting MMI (10\u2005mg\/day). Laboratory evaluation showed positive antinuclear antibodies and anti-histone antibodies, reduced complement C3 and low-normal C4, and negative anti-double-stranded DNA and extractable nuclear antigen antibodies; urinalysis was normal. MMI was discontinued and oral prednisone (20\u2005mg\/day) initiated, resulting in marked improvement within 1\u2005week and complete symptom resolution by days 10\u201314. This presentation is notable for the unusually rapid onset of MMI-associated DILE in an adolescent and the presence of alopecia, a feature more typical of idiopathic systemic lupus erythematosus (SLE) than classic DILE. The case underscores the importance of maintaining a high index of suspicion for DILE shortly after antithyroid drug initiation, carefully differentiating it from idiopathic SLE using serology and clinical course, and promptly withdrawing the offending agent. Early recognition and short courses of corticosteroids can lead to rapid and complete recovery, while avoiding unnecessary investigations or prolonged morbidity.<\/jats:p>","DOI":"10.3389\/fped.2025.1687328","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T06:29:45Z","timestamp":1765175385000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Rapid-onset methimazole-induced lupus in a pediatric patient with Graves\u2019 disease: a case report and review of the literature"],"prefix":"10.3389","volume":"13","author":[{"given":"Nouraldeen","family":"Deeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salahaldeen","family":"Deeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Badawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Alfrookh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashar","family":"Douden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saed I.","family":"Atawnah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e62023","DOI":"10.7759\/cureus.62023","article-title":"Diagnosis of Graves\u2019 disease and methimazole-induced lupus erythematosus in an adolescent male during the COVID-19 era: a case report","volume":"16","author":"Kumar","year":"2024","journal-title":"Cureus"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e927929","DOI":"10.12659\/ajcr.927929","article-title":"Antithyroid drug-induced lupus erythematosus and immunoglobulin a deficiency","volume":"21","author":"Beernaert","year":"2020","journal-title":"Am J Case Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1196\/annals.1422.019","article-title":"Drug-induced lupus","volume":"1108","author":"Borchers","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.clindermatol.2003.12.023","article-title":"Drug-induced lupus erythematosus","volume":"22","author":"Antonov","year":"2004","journal-title":"Clin Dermatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1177\/0961203314523871","article-title":"Drug-induced lupus: including anti-tumour necrosis factor and interferon induced","volume":"23","author":"Ara\u00fajo-Fern\u00e1ndez","year":"2014","journal-title":"Lupus"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1177\/09612033241272964","article-title":"Evaluation of thyroid dysfunction in childhood-onset systemic lupus erythematosus: risk factors for Hashimoto\u2019s thyroiditis","volume":"33","author":"Konte","year":"2024","journal-title":"Lupus"},{"key":"B7","doi-asserted-by":"publisher","first-page":"336","DOI":"10.5152\/turkarchpediatr.2024.24097","article-title":"Revisiting childhood-onset systemic lupus erythematosus","volume":"59","author":"Avar-Ayd\u0131n","year":"2024","journal-title":"Turk Arch Pediatr"},{"key":"B8","first-page":"278","article-title":"Methimazole-induced lupus erythematosus: a case report","volume":"36","author":"Wang","year":"2003","journal-title":"J Microbiol Immunol Infect"},{"key":"B9","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3346\/jkms.2012.27.7.818","article-title":"Methimazole-induced bullous systemic lupus erythematosus: a case report","volume":"27","author":"Seo","year":"2012","journal-title":"J Korean Med Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1080\/00015550260132523","article-title":"Methimazole-induced antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and lupus-like syndrome with a cutaneous feature of vesiculo-bullous systemic lupus erythematosus","volume":"82","author":"Thong","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/0961203312467668","article-title":"Lupus nephritis and non-Hodgkin lymphoma simultaneously diagnosed in a patient on methimazole","volume":"22","author":"Lionaki","year":"2012","journal-title":"Lupus"},{"key":"B12","article-title":"Drug-induced lupus erythematosus","volume-title":"StatPearls","author":"Solhjoo","year":"2023"},{"key":"B13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1590\/2359-3997000000113","article-title":"Anti-thyroid drug-induced lupus: a case report and review of the literature","volume":"60","author":"Mei","year":"2015","journal-title":"Arch Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1111\/jdv.13857","article-title":"Methimazole-induced chronic cutaneous lupus erythematosus","volume":"31","author":"Venturi","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.37275\/bsm.v9i1.1177","article-title":"A rare case of antithyroid drug-induced lupus erythematosus, Graves\u2019 disease, and primary infertility","volume":"9","author":"Kusuma","year":"2024","journal-title":"BioSci Med J Biomed Transl Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.31138\/mjr.29.1.52","article-title":"Antithyroid drug induced syndrome that lies in between ANCA vasculitis and lupus-like syndrome in a 40-year-old female with Graves\u2019 disease under methimazole therapy: a case report","volume":"29","author":"Nikitopoulou","year":"2018","journal-title":"Mediterr J Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1365-2230.1995.tb01340.x","article-title":"ANCA-associated vasculitis and lupus-like syndrome caused by methimazole","volume":"20","author":"Kawachi","year":"1995","journal-title":"Clin Exp Dermatol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1687328\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T06:29:46Z","timestamp":1765175386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1687328\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":17,"alternative-id":["10.3389\/fped.2025.1687328"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1687328","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"article-number":"1687328"}}